Screening for Breast Cancer

Anand K Narayan; Christoph I Lee; Constance D Lehman

doi:10.1016/j.mcna.2020.08.003

Screening for Breast Cancer

Med Clin North Am. 2020 Nov;104(6):1007-1021. doi: 10.1016/j.mcna.2020.08.003.

Authors

Anand K Narayan¹, Christoph I Lee², Constance D Lehman³

Affiliations

¹ Radiology, Massachusetts General Hospital, 55 Fruit Street, Wang 240, Boston, MA 02114, USA. Electronic address: https://twitter.com/AnandKNarayan.
² Department of Radiology, Department of Health Services, Northwest Screening and Cancer Outcomes Research Enterprise, University of Washington, 1144 Eastlake Avenue East, LG-212, Seattle, WA 98109, USA.
³ Radiology, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Wang Building, Suite 219L, Boston, MA 02114, USA.

PMID: 33099447
DOI: 10.1016/j.mcna.2020.08.003

Abstract

Among women, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer-related death in the world. The purpose of this article is to review the evidence regarding breast cancer screening for average-risk women. The review primarily focuses on mammographic screening but also reviews clinical breast examinations, emerging screening technologies, and opportunities to build consensus. Wherever possible, the review relies on published systematic reviews, meta-analyses, and guidelines from three major societies (US Preventive Services Task Force, American College of Radiology, and the American Cancer Society) to reflect a range of evidence-based perspectives regarding mammographic screening.

Keywords: Cancer screening guidelines; Health care providers; Mammography; Screening.

Publication types

Review

MeSH terms

Breast Neoplasms / diagnostic imaging*
Female
Humans
Mammography / standards
Mammography / statistics & numerical data*
Practice Guidelines as Topic*
United States